Company Overview of G1 Therapeutics, Inc.
G1 Therapeutics, Inc. researches and develops small molecule therapies to address unmet needs in oncology. It offers programs including G1T28-1, to protect bone marrow and other organs from side effects of chemotherapy treatments and radiation. The company was formerly known as G-Zero Therapeutics Inc. G1 Therapeutics, Inc. was founded in 2008 and is based in Research Triangle Park, North Carolina.
79 T.W. Alexander Drive
4401 Research Commons
Research Triangle Park, NC 27709
Founded in 2008
Key Executives for G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Emergent Product Development Seattle LLC||United States|
|Kucera Pharmaceutical Company||United States|
|Myomics, Inc.||United States|
|MultiCell Immunotherapeutics, Inc.||United States|
|Cloud Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact G1 Therapeutics, Inc., please visit www.g1therapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.